Spectrum Pharmaceuticals (SPPI)

Add to Watchlists Create an Alert
8.33 -0.22  -2.57%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Spectrum Pharmaceuticals News

Biotech Stock Mailbag: Amarin, MannKind, Palatin
May 24

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.

Spectrum Pharmaceuticals to Present Corporate Update at the Deutsche Bank 38th Annual Health Care Conference in Boston on May 30th
Business Wire May 23

Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Deutsche Bank 38th Annual Health Care Conference being held at The Westin Boston Waterfront Hotel in ...

Spectrum Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 03:30 PM
Seeking Alpha May 20

Spectrum Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 03:30 PM

Spectrum Pharmaceuticals' CEO Presents at UBS Global Healthcare Conference (Transcript)
Seeking Alpha May 20

Spectrum Pharmaceuticals' CEO Presents at UBS Global Healthcare Conference (Transcript)

Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
May 17

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.

Spectrum Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
Seeking Alpha May 14

Spectrum Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)

Spectrum Pharma Reports 1Q Loss - Analyst Blog
Zacks May 14

Spectrum Pharma reported first quarter of 2013 loss of 14 cents per share, narrower than the Zacks Consensus Estimate of a loss of 32 cents.

Spectrum Pharmaceuticals to Present Corporate Update at the UBS Global Healthcare Conference in New York City on May 20th
Business Wire May 13

Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the UBS Global Healthcare Conference being held at Sheraton New York Hotel in New York City.

Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
SPPI 8.33 -0.22 -2.57% 501.11M
New watchlist
Create
Success.

Your new watchlist has been created

View WatchlistsDone
Create Watchlist from Quotes

Register for your Free YCharts Account.

Understand your investments with more data than any other free site.

  • Create watchlists that you care about for stocks or economic indicators
  • Create alerts to track the movements of your stocks
  • Access stock analysis from our in-house experts
Get Started Now

Already registered? Sign in to your account.

document.write('');